Century Therapeutics (IPSC) analysis: autoimmune CAR-cell pivot, CNTY-813 Type 1 diabetes upside, cash burn cuts, rNPV fair ...
Bristol Myers Squibb's valuation metrics show the stock is a bona fide bargain. However, valuation metrics can be misleading ...
Bristol Myers Squibb has the first positive phase 3 results under its belt for mezigdomide, a second experimental drug in its much-trumpeted celmod development programme for multiple myeloma. Interim ...
From its earlier days gaining traction with anesthesiologists, simulation is now a mainstay of medical education that helps ...
Bristol-Myers Squibb is having a busy holiday period, signing a $4.1 billion deal to acquire cancer drug developer RayzeBio – its second multibillion-dollar M&A deal in the space of a week. BMS is ...
BAE Systems has developed an Artificial Intelligence (AI)-driven role-player capability for its Mimesis maritime battle ...
Training AI world models on data about physical environments could improve their real-world capabilities in technologies such ...
Caroline Banton has 6+ years of experience as a writer of business and finance articles. She also writes biographies for Story Terrace. Vikki Velasquez is a researcher and writer who has managed, ...
Abstract: As power grid scale continues to expand and complexity increases, traditional grid analysis methods face challenges in computational efficiency and accuracy. Developing an efficient and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results